D.E. Shaw & Co’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
D.E. Shaw & Co's ACLS Position: Q2 2026 in Review
D.E. Shaw & Co reduced its Axcelis (ACLS) stake by 76% in Q2 2026, selling an estimated $61M and leaving 133,044 shares worth $25.2M. The position accounts for 0.01% of the portfolio, ranked #1139.
D.E. Shaw & Co first reported a position in ACLS in Q2 2013 and has held it in 41 quarters since. The position peaked at $50.7M in Q1 2026. 440 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- D.E. Shaw & Co held 133,044 shares of Axcelis worth $25.2M as of Q2 2026.
- D.E. Shaw & Co sold 411,377 Axcelis shares in Q2 2026, an estimated $61M.
- Axcelis made up 0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1139 holding.
- D.E. Shaw & Co first reported a position in Axcelis in Q2 2013 and has held it in 41 quarters since.
- D.E. Shaw & Co's Axcelis position peaked at $50.7M in Q1 2026.
- 440 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.